Racial,ethnic and socioeconomic disparities in the treatment of brain tumors |
| |
Authors: | Jr" target="_blank">William T CurryJr II" target="_blank">Fred G BarkerII |
| |
Institution: | (1) Department of Surgery (Neurosurgery), Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Yawkey 9E, Fruit Street, Boston, MA 02114, USA |
| |
Abstract: | Disparities in American health care based on socially-defined patient characteristics such as race, ethnicity, and socioeconomic
position are well-documented. We review differences and disparities in incidence, pathobiology, processes and outcomes of
care, and survival based on social factors for brain tumors of all histologies. In the US, black patients have lower incidences
of most brain tumor types and lower-income patients have lower incidences of low grade glioma, meningioma and acoustic neuroma;
ascertainment bias may contribute to these findings. Pathogenetic differences between malignant gliomas in patients of different
races have been demonstrated, but their clinical significance is unclear. Patients in disadvantaged groups are less often
treated by high-volume providers. Mortality and morbidity of initial treatment are higher for brain tumor patients in disadvantaged
groups, and they present with markers of more severe disease. Long term survival differences between malignant glioma patients
of different races have not yet been shown. Clinical trial enrollment appears to be lower among brain tumor patients from
disadvantaged groups. We propose future research both to better define disparities and to alleviate them. |
| |
Keywords: | Race Ethnicity Socioeconomic status Health care disparities Health care quality |
本文献已被 SpringerLink 等数据库收录! |
|